Milestone Pharmaceuticals Inc. ($MIST)
Filing Information
| Accession Number | 0001771207-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 28, 2026 |
| Document Date | Dec 12, 2025 |
| Document | View SEC Filing |
Transactions
6
Total Shares
304,946
Total Value
$145,850.52
P&L
+inf% (+$170,000.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common Shares | โ | Dec 12, 2025 | Grant/Award | 100,000 | โ | โ | 250,052 | Direct | โ | View Details | |
Chief Commercial Officer | Common Shares | โ | Dec 15, 2025 | Sale | 53,566 | $2.32 | $124,273.12 | 196,486 | Direct | โ | View Details | |
Chief Commercial Officer | Common Shares | โ | Jan 26, 2026 | Exercise/Conversion | 20,100 | โ | โ | 216,586 | Direct | โ | View Details | |
Chief Commercial Officer | Common Shares | โ | Jan 26, 2026 | Sale | 11,180 | $1.93 | $21,577.40 | 205,406 | Direct | โ | View Details | |
Chief Commercial Officer | Employee Stock Option (right to buy) | Derivative | Dec 12, 2025 | Grant/Award | 100,000 | $0.00 | $0.00 | 100,000 | Direct | โ | View Details | |
Chief Commercial Officer | Restricted Stock Units | Derivative | Jan 26, 2026 | Exercise/Conversion | 20,100 | $0.00 | $0.00 | 60,300 | Direct | โ | View Details |